ARTPER
Research Group (peripheral arteriopathy)
The objective of the ARTPER group is to deep in the knowledge of peripheral arterial disease: epidemiology (prevalence, incidence), diagnostic and prognostic risk factors and its relationship with the appearance of vascular events (morbidity and mortality). In 2006 a multicentre cohort was recruited (3786 people> 49 years) with the objective of knowing the prevalence of Peripheral Arteriopathy. In 2011 the cohort was cited in person to determine the incidence of peripheral arterial disease.
Group projects
|
PI: Ramos Blanes, Rafel. Predicción del Riesgo vascular en pOblación de edad avanzada del mediTErraneO. Estudio PROTEO. Funding: Instituto de Salud Carlos III. Duration: 2018 - 2020 |
|
PI: Expósito Martínez, Carmen. L'àcid úric com a factor de risc de la malaltia renal crònica, malaltia cardiovascular i fetge gras no alcohòlic. Funding: IDIAP Jordi Gol. Duration: 2017 - 2019 |
The group participates in the following projects
|
PI: Mataró Serrat, Maria. Exercise the Mind and Brain. A Multimodal intervention in stroke. Funding: Fundacio La Marato de TV3. Duration: 2018 - 2020 |
|
PI: Caballería Rovira, Llorenç. Screening for liver fibrosis. A population-based study in European countries. The LiverScreen project. Funding: Gilead Sciences, S.L.U. Duration: 2018 - 2020 |
|
PI: Martínez Sánchez, Nuria. Estudi comparatiu entre dos mètodes de mesura en la determinació de la diferència de pressió arterial entre braços. Funding: IDIAP Jordi Gol. Duration: 2018 - 2019 |
|
PI: Mataró Serrat, Maria. Estudio de integración ómica de los efectos neurobiológicos del ejercicio físico y la estimulación cognitiva. Funding: Ministerio de Economía y Competitividad. Duration: 2017 - 2019 |
|
PI: Alzamora Sas, Mª Teresa. Morbimortalidad cardiovascular y no cardiovascular a los 10 años de seguimiento de la cohorte poblacional ARTPER. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2019 |
|
PI: Caballería Rovira, Llorenç. Valor predictivo de la elastografía hepática transitoria respecto a la enfermedad hepática y cardiovascular. Funding: Instituto de Salud Carlos III. Duration: 2015 - 2019 |
|
PI: Heras Tébar, Antoni. Anàlisis de la ràtio arteriovenosa com a factor de risc cardiovascular en la cohort ARTPER. Estudi Retino-ARTPER. Funding: ICS - Institut Català de la Salut. Duration: 2018 |
|
PI: López-Cancio Martínez, Elena. Aterosclerosis cervico-cerebral, ictus y deterioro cognitivo incidentes en la cohorte poblacional AsIA. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2018 |
The group participates in the following publications
|
Baena-Díez JM, Garcia-Gil M, Comas-Cufí M, Ramos R, Prieto-Alhambra D, Salvador-González B, Elosua R, Dégano IR, Peñafiel J, Grau M. Association between chronic immune-mediated inflammatory diseases and cardiovascular risk. Heart. 2018 Jan;104(2):119-126. doi: 10.1136/heartjnl-2017-311279. Epub 2017 Aug 28. PubMed PMID: 28847852. IF: 6,059. |
|
Baena-Díez JM, Subirana I, Ramos R, Gómez de la Cámara A, Elosua R, Vila J, Marín-Ibáñez A, Guembe MJ, Rigo F, Tormo-Díaz MJ, Moreno-Iribas C, Cabré JJ, Segura A, Lapetra J, Quesada M, Medrano MJ, González-Diego P, Frontera G, Gavrila D, Ardanaz E, Basora J, García JM, García-Lareo M, Gutiérrez-Fuentes JA, Mayoral E, Sala J, Dégano IR, Francès A, Castell C, Grau M, Marrugat J. Validity Assessment of Low-risk SCORE Function and SCORE Function Calibrated to the Spanish Population in the FRESCO Cohorts. Revista espanola de cardiologia (English ed.). 2018 Apr; 71(4):274-282. doi:10.1016/j.rec.2017.03.030. Epub 2017 May 26. PMID:28566245. IF: 4,485. |
|
Barroso M, Goday A, Ramos R, Marín-Ibañez A, Guembe MJ, Rigo F, Tormo-Díaz MJ, Moreno-Iribas C, Cabré JJ, Segura A, Baena-Díez JM, de la Cámara AG, Lapetra J, Quesada M, Medrano MJ, Berjón J, Frontera G, Gavrila D, Barricarte A, Basora J, García JM, García-Lareo M, Lora-Pablos D, Mayoral E, Grau M, Marrugat J; FRESCO Investigators. Interaction between cardiovascular risk factors and body mass index and 10-year incidence of cardiovascular disease, cancer death, and overall mortality. Preventive medicine. 2018 02; 107:81-89. doi:10.1016/j.ypmed.2017.11.013. Epub 2017 Nov 16. PMID:29155226. IF: 3,434. |
|
Caballería L, Pera G, Arteaga I, Rodríguez L, Alumà A, Morillas RM, de la Ossa N, Díaz A, Expósito C, Miranda D, Sánchez C, Prats RM, Urquizu M, Salgado A, Alemany M, Martinez A, Majeed I, Fabrellas N, Graupera I, Planas R, Ojanguren I, Serra M, Torán P, Caballería J, Ginès P. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2018 Jul; 16(7):1138-1145.e5. doi:10.1016/j.cgh.2017.12.048. Epub 2018 Feb 13. PMID:29452268. IF: 7,398. |
|
de Hoyos Alonso MDC, Gorroñogoitia Iturbe A, Martín Lesende I, Baena Díez JM, López-Torres Hidalgo J, Magán Tapia P, Acosta Benito MÁ, Herreros Herreros Y; Grupo de Actividades Preventivas en los Mayores del PAPPS. . Atencion primaria. 2018 May; 50 Suppl 1:109-124. doi:10.1016/S0212-6567(18)30365-2. Spanish. PMID:29866352. IF: 1,042. |
|
Forés R, Alzamora MT, Pera G, Baena-Díez JM, Mundet-Tuduri X, Torán P. Correction: Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort. PloS one. 2018 ; 13(5):e0197139. doi:10.1371/journal.pone.0197139. Epub 2018 May 07. pmc:PMC5937770. PMID:29734376. IF: 2,806. |
|
Forés R, Alzamora MT, Pera G, Baena-Díez JM, Mundet-Tuduri X, Torán P. Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort. PLoS One. 2018 Jan 16;13(1):e0191283. doi: 10.1371/journal.pone.0191283. eCollection 2018. PMID:29338049. IF: 2,806. |
|
Morros R, Vedia C, Giner-Soriano M, Casellas A, Amado E, Baena JM; en representaci?n de los investigadores del proyecto PNEUMOCORT. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT. Atencion primaria. 2018 Apr; doi:10.1016/j.aprim.2018.02.007. Epub 2018 Apr 13. Spanish. PMID:29661670. IF: 1,042. |
|
Real J, Serna MC, Giner-Soriano M, Forés R, Pera G, Ribes E, Alzamora M, Marsal JR, Heras A, Morros R. Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database. BMC cardiovascular disorders. 2018 May; 18(1):85. doi:10.1186/s12872-018-0822-4. Epub 2018 May 08. PMID:29739318. IF: 1,832. |
|
Salvador-González B, Gil-Terrón N, Cerain-Herrero MJ, Subirana I, Güell-Miró R, Rodríguez-Latre LM, Cunillera-Puértolas O, Elosua R, Grau M, Vila J, Pascual-Benito L, Mestre-Ferrer J, Ramos R, Baena-Díez JM, Soler-Vila M, Alonso-Bes E, Ruipérez-Guijarro L, Álvarez-Funes V, Freixes-Villaró E, Rodríguez-Pascual M, Martínez-Castelao A. Estimated Glomerular Filtration Rate, Cardiovascular Events and Mortality Across Age Groups Among Individuals Older Than 60 Years in Southern Europe. Revista espanola de cardiologia (English ed.). 2018 Jun; 71(6):450-457. doi:10.1016/j.rec.2017.09.010. Epub 2017 Oct 28. PMID:29111335. IF: 4,485. |
Awards
|
Premi a la millor publicació en atenció primària. Premis Sanitat Baix Llobregat 2018 del Col.legi de Metges de Barcelona. Revista española de cardiologia. Tasa de filtrado glomerular estimada, eventos cardiovasculares y mortalidad por grupos de edad en individuos de 60 o más años del sur de Europa. Salvador B, Gil N, Cerain MJ, Subirana I, Güell R, Rodríguez LM, Cunillera O, Elosua R, Grau M, Vila J, Pascual ML, Mestre J, Ramos R, Baena JM, Soler M, Alonso E, Ruipérez L, Alvarez V, Freixes E, Rodríguez M, Martínez-Castelao A. |
Indicators
|
Indicator |
2018 |
|---|---|
|
Researchers with PhD |
4 |
|
Total number of projects in which group members have participated |
10 |
|
Total number of projects in which the PI of the project has belonged to the group |
2 |
|
Total Funding |
579.828,10€ |
|
Scientific publications in indexed journals |
10 |
|
Total Impact factor |
35,39 |
|
Nº of articles in Q1 journals |
5 |
|
Q1 IF |
22,503 |
|
Nº of articles in Q2 journals |
2 |
|
Q2 IF |
8,97 |
